However, in high-OXPHOS melanomas, MITF is not suppressed by HIF1α but is promoted by the mammalian target of rapamycin (mTOR), leading to the transcription of PGC1α, a transcriptional coactivator which induces the expression of different OXPHOS genes [11]. The gene discussed is MTOR; the disease is melanoma.